The transport and Golgi organization 1 (TANGO1) family proteins have been shown to play 2 pivotal roles in the secretory pathway. Full length TANGO1 is a transmembrane protein 3 localised at endoplasmic reticulum exit sites (ERES), where it binds bulky cargo within the 4 ER lumen and recruits membranes from the ER Golgi intermediate compartment (ERGIC) to 5 create an exit route for their export. Tango1 knockout mice display a global collagen 6 secretion defect and perinatal lethality. Here we report the first TANGO1-associated 7 syndrome in humans, which mainly manifests in a collagenopathy. A synonymous 8 substitution that results in exon 8 skipping in most mRNA molecules, ultimately leading to a 9 truncated TANGO1 protein was identified as the disease-causing mutation. The four 10 homozygously affected sons of a consanguineous family display severe dentinogenesis 11 imperfecta, short stature, various skeletal abnormalities, insulin-dependent diabetes mellitus, 12 sensorineural hearing loss, and mild intellectual disability. Functional studies in HeLa and 13 U2OS cells revealed that the corresponding truncated TANGO1 protein is dispersed in the 14 ER and its expression in cells with intact endogenous TANGO1 impairs cellular collagen I 15 secretion. 16 17 18
Introduction 1
Collagens are the most abundantly secreted molecules in mammals and needed throughout 2 the whole body for bone mineralization, skin and tissue assembly. Within the endoplasmic 3 reticulum (ER) lumen, newly synthesized procollagens assemble into rigid, rod-like triple 4 helices that are too large for export by the conventional coat protein complex II (COPII)-5 coated vesicle size of 60-90 nm (Malhotra and Erlmann, 2015; Miller and Schekman, 2013) . 6
Over the past years, the ER exit site (ERES) located, transport and Golgi organization 1 7 protein (TANGO1) has been identified as the key player in the export of hard to fold and 8 bulky cargoes like the collagens (Bard et al., 2006; Erlmann, 2011, 2015 ; Saito 9 et al., 2009; Santos et al., 2016; Raote et al., 2017 Raote et al., , 2018 Raote and Malhotra, 2019; Wilson 10 et al., 2011) . TANGO1 is conserved throughout most metazoans and ubiquitously expressed 11 in humans. It comprises 8,142 bp located at chromosome 1q41 and encodes two distinct 12 isoforms, full length TANGO1 and TANGO1-short. Full length TANGO1 consists of 1,907 13 amino acids (aa) and contains an N-terminal signal sequence followed by an Src-homology 3 14 (SH3)-like domain and a coiled-coil domain in the lumenal portion, as well as two additional 15 coiled-coil domains (CC1 and CC2) and a proline-rich domain (PRD) in the cytoplasmic 16 portion ( Figure 1A) . TANGO1-short is composed of 785 aa and lacks the lumenal portion 17 contained in TANGO1 (Saito et al., 2009) . Together with cTAGE5 encoded by the TANGO1-18 like protein gene (TALI), TANGO1 and TANGO1-short form stable complexes at ERES, to 19 jointly fulfill their roles in the secretion of bulky cargoes such as procollagens, pre-20 chylomicrons, and large pre-very low-density-lipoproteins (Bosserhoff et al., 2003; Maeda et 21 al., 2016; Erlmann, 2011, 2015; Malhotra et al., 2015; Saito et al., 2009 Saito et al., , 2011 22 Santos et al., 2016; Wilson et al., 2011) . 23 At ERES TANGO1 assembles into rings that enclose COPII coats and create a sub-24 compartment dedicated to sorting, packing and exporting collagens (Raote et al., 2017, 25 2018; Raote and Malhotra, 2019) . TANGO1's SH3-like domain binds collagens via the 26 collagen-specific chaperone HSP47 (heat shock protein 47) in the ER lumen (Ishikawa et al., 27 2016) . This binding of TANGO1 to HSP47-Collagen is proposed to trigger binding of its PRD 28 6 1 Whole exome sequencing (WES) revealed the disease-causing mutation in TANGO1 2 WES was performed in the four affected bothers and their parents. After filtering, 10 variants 3 were found to be homozygous in all affected children and heterozygous in both parents. In-4 depth data analysis revealed a synonymous variant in exon 8 of TANGO1 5 (NM_001324062.1: c.3621A>G) as the most likely disease-causing mutation. TANGO1 is 6 known to be crucial for the secretion of collagens, consistent with a collagenopathy in our 7 patients. WES results were validated by Sanger sequencing (Figure 2A) . This TANGO1 8 mutation was not present in large population databases such as ExAC or gnomAD. Although 9 it does not alter the amino acid at the respective position (p.(Arg1207=)), the A>G 10 (Figure supplement 1A) . The mutation affects 2 residue 1,207 between the intramembrane and the CC1 domain within the cytoplasmic 3 portion of TANGO1 ( Figure 1A) . 4
Homozygosity mapping of two affected brothers (II.1 and II.2) identified a shared 5 homozygous interval of ~19 Mb on chromosome 1, spanning GRCh37/hg19 coordinates 6 214,413,099-233,429,284 (rs12736101-rs6656327), including TANGO1 and 28 disease-7 causing OMIM genes (Figure supplement 1B,C) . Apart from TANGO1, none of the shared 8 homozygous intervals was endowed with a pathogenic mutation. In addition, no potentially 9 disease-causing copy number variation (CNV) was detected by array comparative genomic 10 hybridization (CGH). 11
12
The TANGO1 mutation leads to exon 8 skipping by disrupting an exon splice enhancer 13
both in vivo and in vitro 14
In order to investigate possible effects of the identified TANGO1 mutation on pre-mRNA 15
splicing, blood samples of the whole family were used for RNA isolation and reverse 16 transcription PCR. Subsequent gel electrophoresis and cDNA sequencing revealed two 17 splice products in the homozygous sons and their heterozygous parents, one representing 18 the full length transcript being more abundant in the parents and another one lacking the 19 entire exon 8 being more abundant in the affected sons ( Figure 
9
(D) Consequences of TANGO1 exon 8 skipping on the reading frame and the amino acid level.
10
Exclusion of exon 8 causes a premature stop codon.
9
A minigene assay (Figure supplement 2) was performed to confirm that the identified 1 TANGO1 mutation is sufficient to induce exon 8 skipping. Transfection of cultured HEK293T 2 cells with the Mnt vector carrying the mutated (c.3621A>G) TANGO1 exon 8 and 250 bp 3 flanking intronic sequences mainly produced vector-derived splice products lacking exon 8. 4
The observed splicing error could be due to disruption of an ESE motif recognized by the 5 SR protein SC35 or to formation of a splice repressor motif recruiting the heterogeneous 6 nuclear ribonucleoprotein A1 (hnRNP A1). To test this, cultured HeLa cells were transfected 7 with either a wild-type or a mutated TANGO1 vector (Figure supplement 3) and then treated 8 with a customized antisense oligonucleotide (vivo morpholino) targeting the entire TANGO1 9 exon 8. SR proteins are required for proper exon inclusion during splicing and their absence 10 can lead to exon skipping. The observed effects of the morpholino treatment on TANGO1 11 splicing support the idea that the c.3621A>G mutation interferes with SR protein binding. 12
13
The homozygous TANGO1 mutation results in exon 8 skipping in most splice products 14
Quantitative real-time (qRT) PCR on blood cDNA samples was performed to quantify the 15 amount of mutant and normal TANGO1 splice products, respectively, in homozygous and 16 heterozygous mutation carriers compared to a normal control ( Figure 3) . The affected 17 children consistently displayed the lowest amounts of normal splice product (mean RQ value: 18 0.39) and the highest amounts of the exon 8 skipped product (mean RQ value: 4.58). Both 19 parents showed more normal splice product (mean RQ value: 0.59) than their children but 20
still only approximately half of that of the control. In contrast to the control individual, both 21 parents also displayed a considerable proportion of the exon 8 skipped splice product (mean 22 RQ value: 2.66). Because of a processed transcript (ENST00000495210.1) without exon 8 23 which is probably co-amplified by reverse transcription PCR, the exact ratios of the mutant 24 versus the normal splice product could not be determined. Unfortunately, it was not possible 25
to design specific primers for the aberrant exon 8 skipped splice product. In a homozygous 26 state, the TANGO1 c.3621A>G mutation leads to exon 8 skipping in most splice products, 27
whereas in the heterozygous parents the normal splice product is more abundant. 
7
The truncated TANGO1 protein does not localise to ER exit sites 8
To test the properties of the truncated TANGO1 protein, TANGO1 lacking exon 8 (Ex8-HA) 9
was expressed in cultured HeLa cells, from which endogenous TANGO1 was knocked out 10 (HeLa∆TANGO1) using CRISPR/Cas9 methodology (Santos et al., 2015) . HeLa∆TANGO1 11 cells were transiently transfected with cDNA for either wild-type TANGO1-HA or Ex8-HA 12 ( Figure 4 ). 48h after transfection, cells were fixed, permeabilised and immunostained for HA 13 and the ERES marker Sec16A. WT TANGO1-HA (green) expressed in distinct puncta, which 14 colocalised with Sec16A (red). On the other hand, Ex8-HA (green) was distributed in a more 15 diffused pattern throughout the cell and it did not localise to ERES (red) ( Figure 4A) . 16
Transfected HeLa∆TANGO1 cells were probed with anti-HA and anti-Calreticulin (an ER-17 resident chaperone). WT TANGO1-HA (green) did not show any association with calreticulin 18 (red), while Ex8-HA (green) was almost entirely colocalised with calreticulin (red) ( Figure 4B) . 19
These data are consistent with our understanding of TANGO1 function, as its cytoplasmic 20 domains are required to recruit TANGO1 to ERES. The Ex8 mutant lacks any cytoplasmic 21 domains and consequently is distributed through the ER. All affected individuals showed the highest amounts of the exon 8 skipped splice product 9 compared to the normal TANGO1 splice product ( Figure 3 ). However, it was not possible to 10 determine how the relative abundance of the two splice products translated to protein levels 11 in patient-derived samples. Therefore, possible effects of the overexpression of Ex8-HA on 12 top of endogenous levels of normal TANGO1 splice product at the cellular level were 13 investigated using human osteosarcoma U2OS as a model system. U2OS cells produce and 14 rapidly secrete collagen I, so they are the ideal system to monitor possible effects of Ex8-HA 15 overproduction on collagen homeostasis. For this purpose, a stable U2OS cell line 16 expressing Ex8-HA under a constitutive promoter was generated and compared with wild-17 type cells by microscopy. Cells expressing Ex8-HA showed weaker and more diffuse staining 18 of collagen I compared with control cells (Figure supplement 4A ). To confirm that this 1 reduction was not due to unequal immunofluorescent staining, total RNA was isolated from 2 the two cell populations and the relative amount of collagen I/GAPDH transcript was 3 quantified by qRT-PCR analyses (Figure supplement 4B ). This confirmed that collagen I 4 expression is reduced in the Ex8-HA stable cell line. 
16
The next step was to test whether the secretion of collagen I was also affected. Since 17 different rates of collagen synthesis will affect the amount available for secretion in the two 18 cell populations, a cycloheximide chase experiment was performed ( Figure 5 ). By inhibiting 19 protein synthesis, it was possible to monitor the rate of secretion of the available pool of 20 collagen I present in the cells at time zero. By quantifying the relative amount of collagen I 21 present in the cells and in the media at each time point, a drastic reduction in the rate of 22 collagen I secretion from the EX8-HA stable cell line compared to control cells was observed. 23
Importantly, this effect was not due to a general reduction of protein secretion since the small 24 cargo antitrypsin was produced and secreted at a comparable rate in the two cell 25 13 populations. Collectively, these results show that expression of the exon 8 skipped splice 1 product even in the presence of full length TANGO1 affects collagen I homeostasis. The skipped exon 8 in full length TANGO1 corresponds to exon 3 in the isoform 22 TANGO1-short. Its exclusion there also leads to a premature stop codon 27 bp downstream 23 of exon 2. TANGO1-short has a similar structure to TANGO1, but lacks the lumenal portion 24 within the cargo-binding SH3 domain. However, TANGO1-short has been shown to 25 substitute the function of TANGO1 in collagen export, and vice versa (Maeda et al., 2016) . It 26 has been postulated that the cytoplasmic portion's capacity to recruit ERGIC-53 membranes, 27
Sec23/24 complexes, and cTAGE5, shared by both isoforms, is sufficient to export collagen 28 at the ER (Santos et al., 2015; Saito et al., 2009) . The lumenal SH3 domain may therefore 1 rather play a role in modulating the efficiency or the quality (folding status) of collagens to be 2 secreted (Maeda et al., 2016; Raote et al., 2018; Saito et al., 2009 ). Since the identified 3 mutation in exon 8 does not only compromise the function of TANGO1, but most likely also of 4 TANGO1-short, the short isoform cannot attenuate our patients' phenotype. 5
The truncated TANGO1 protein is unable to access ERES and is distributed throughout 6 the ER (Figure 4) . Its expression in cells with endogenous full length TANGO1 displayed a 7 negative effect on collagen secretion. This effect is specific to collagen, as the secretion of 8 antitrypsin remains unaffected ( Figure 5) . It is conceivable that the truncated TANGO1 9 sequesters HSP47 away from ERES, which usually assists in collagen folding and export 10 from the ER. It was recently shown that HSP47 may play a key role in modulating the 11 unfolded protein response (UPR) by directly binding to the inositol-requiring enzyme 1 alpha 12 (IRE1α) sensor (Sepulveda et al., 2018) , thereby affecting the folding and the secretory 13 capacity of the cell according to collagen production. An interesting speculation arising from 14 our data would be that the HSP47/UPR axis has a bidirectional function -limiting collagen 15 biogenesis when the secretory capacity is attenuated. 16
Type I collagens provide tensile strength to connective tissue and are abundant in bone, 17 skin, dentin, cementum, tendons, and ligaments (Desmukh et al., 2016) . Impaired collagen I 18 secretion may underlie several key symptoms in our patients, in particular the tooth and 19 skeletal abnormalities. However, the complex phenotype of the probands suggests that 20 TANGO1 may also be involved in the secretion of further types of collagens, e.g. COL2A1, 21 COL4A3, COL4A4, COL4A5, COL4A6, COL9A1, COL9A2 und COL9A3, COL11A1, and/or 22 COL11A2, which are all important for inner ear function and associated with hereditary 23 hearing loss (https://hereditaryhearingloss.org/). Defective secretion of other molecules, in 24 particular hormones, may cause diabetes mellitus and pubertas praecox. Endocrinological 25 examination revealed that the glucose intolerance of the affected children is due to reduced 26 levels of secreted insulin. cTAGE5 is known to cooperate with TANGO1 in the mega cargo 27 secretion pathway (Saito et al, 2011 ), but has also been shown to play a pivotal role in ER to 28 1 cTAGE5 in pancreatic β-cells resulted in defective islet structure, reduced insulin secretion, 2 and severe glucose intolerance in mice (Fan et al., 2017) . Additionally, a correlation between 3 TANGO1 phosphorylation and proinsulin trafficking in mouse pancreatic β-cells has recently 4 been discovered (Kang et al., 2019) . In this light, it will be intriguing to investigate the role of 5 TANGO1 in the insulin secretion pathway in future studies. 6
Collectively, the investigated family presents the first TANGO1-associated syndrome in 7 humans, highlighting the role of fully functional TANGO1 in various disease pathways and 8 bringing new potential target molecules of TANGO1 into focus. Belgium). Variants with a coverage of ≤20, a Phred-scaled quality of ≤15, a frequency of ≤20, 25
and a MAF of ≥1% were neglected. Two control samples from healthy individuals were used 26 for filtering out platform artefacts. Alamut Visual (Interactive Biosoftware, Rouen, France) 27 software including prediction tools like SIFT, MutationTaster, and PolyPhen-2 was used for 28 variant prioritization. Potential effects of a variant on pre-mRNA splicing were evaluated by 1
SpliceSiteFinder-like, MaxEntScan, NNSPLICE, GeneSplicer, Human Splicing Finder, 2
ESEfinder, RESCUE-ESE, and EX-SKIP. Population databases like ExAC, gnomAD, and 3 GME revealed whether a variant has been previously found. Protein expression, structure, 4 and functional aspects were investigated with UniProt and The Human Protein Atlas. 5
Information on mouse models was retrieved from the MGI database. To investigate possible effects of the TANGO1 mutation on pre-mRNA splicing, the 2 homozygous individual II.1 was compared to a normal control sample in a minigene assay. 3
The plasmid pSPL3b-cam vector (Burn et al., 1995) is endowed with a chloramphenicol 4 resistance, an SV40 promoter, SD6 and SA2 primer sequences, as well as a multiple cloning 5 site including recognition sites for XhoI and BamHI (Figure supplement 2A) Aliquots of 4x10 15 HEK293T cells were plated into 6-well-plates and transfected with 26 vector constructs (WT, Mnt, or CTRL) using the FuGENE HD Transfection Reagent (Roche). 27
After 24 h of incubation at 37°C, RNA was isolated with the miRNeasy Mini kit (Qiagen, 28 1 (Applied Biosystems), amplified by a touchdown PCR program using SD6 forward and SA2 2 reverse (5'-ATCTCAGTGGTATTTGTGAGC-3') primers, purified with ExoSAP-IT (Applied 3 Biosystems) and finally sequenced. The resulting splice products were compared by gel 4 electrophoresis and cDNA sequencing. Since the Mnt vector produced two separate 5 TANGO1 splice products, individual cDNA molecules were cloned using the TA Cloning Kit 6 and the Dual Promoter (pCRII) protocol (Invitrogen, Carlsbad, California, USA). 7 8 RNA isolation from whole blood samples, cDNA synthesis and sequencing 9
Peripheral blood samples were collected in PAXgene Blood RNA tubes and RNA was 10 isolated using the PAXgene Blood RNA Kit (PreAnalytiX, Hombrechtikon, Switzerland). 11
Reverse transcription was performed with the High Capacity RNA-to-cDNA Kit (Applied 12 Biosystems). cDNA was amplified by a touchdown PCR program using primers located in 13 TANGO1 exon 6 and 11, respectively (fwd 5'-ACACTCCTATGGATGCTATTGATGC-3'; rev 14 
Morpholino assays 24
Effects of different vivo morpholinos on TANGO1 pre-mRNA splicing were tested on HeLa 25 cells with a different genetic background. 2x10 5 HeLa cells in 2 ml DMEM (Sigma-Aldrich) 26 each were plated into the required number of wells of a 6-well-plate and incubated at 37°C 27 for 24 h. Depending on the research question, cells were then transfected with the TANGO1 28 1 transfection, 2 µg vector were suspended in up to 95 µl DMEM and mixed with 6 µl FuGENE 2 HD Transfection Reagent (Roche). The mixture was incubated at room temperature for 3 15 min and then slowly added to the cells. 4
The customized TGO morpholino targets the entire TANGO1 exon 8. A standard control 5 morpholino (GeneTools, Philomath, Oregon, USA) was used to exclude unspecific effects. 6
The vivo morpholinos were added at a final concentration of 5 or 7 µM. After 24 h incubation, 7
the medium was removed, cells were washed with 2 ml 1xPBS, detached with 0.5 ml 8
Trypsin-EDTA Solution (Sigma-Aldrich) and then transferred into 2 ml tubes with 1x PBS. 9
Samples were centrifuged at 3000 g for 5 min at 4°C. Supernatant was removed and RNA 10 isolated using the miRNeasy Mini Kit (Qiagen). cDNA synthesis and sequencing were 11 performed as described above, using vector-specific primers (SD6 and SA2). This ensured 12 that only vector-derived splice products were analysed. Exon skipping during pre-mRNA splicing could be due to disruption of an ESE motif, which prevents the human SR protein SC35 from binding (hypothesis I). On the other hand, the mutation creates a sequence motif (UAGGGU) that is recognised by hnRNP A1, which may repress splicing (hypothesis II). Most morpholinos alter splicing by sterically blocking the snRNP binding sites utilised by the spliceosome, which are usually located in the intron near the splice donor/acceptor junctions. The TGO morpholino used here targets the entire TANGO1 exon 8 but not enough intronic sequences to block snRNP binding sites. It rather obstructs the consensus sequence for SC35 binding. If disruption of a splice enhancer motif is the underlying mechanism, TGO treatment of WT-transfected cells should also prevent 
